openPR Logo
Press release

Insights on the Cancer Anorexia Cachexia Syndrome Drug Market to 2022 | Industry Statistics, Emerging Demands, Forecast to 2028

03-23-2022 08:24 AM CET | Health & Medicine

Press release from: Orion Market Research

The global cancer anorexia cachexia syndrome drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cancer cachexia is a complex metabolic disease syndrome characterised by low body weight (particularly muscle mass) and anorexia in cancer patients. Cancer cachexia has been shown to have a major impact on patients' quality of life (QOL) and prognosis. The term cachexia refers to a loss of body mass, both lean and fat, as a result of a disease state, in this case cancer. Patients with such signs and symptoms have a shorter survival time, have a poor response to chemotherapeutic drugs, and are more toxic to agents. Furthermore, cancer anorexia/cachexia is frequently linked to weakness, weariness, and low quality of life.

To Request a Sample of our Report on Cancer Anorexia Cachexia Syndrome Drug Market: https://www.omrglobal.com/request-sample/cancer-anorexia-cachexia-syndrome-drug-market

The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including partnerships and collaborations, mergers and acquisitions, geographical expansion, and new product launches, to remain competitive in the marketplace. For instance, Adlumiz (generic name: anamorelin hydrochloride) Tablet 50mg (Adlumiz), a ghrelin receptor agonist, was launched in Japan in April 2021 for the treatment of cancer cachexia in malignant tumors of non-small cell lung cancer, gastric cancer, pancreatic cancer, or colorectal cancer. Adlumiz is a ghrelin receptor agonist that is selective, unique, and orally active. The stomach secretes ghrelin, which is an endogenous peptide. Ghrelin stimulates several pathways in the positive regulation of body weight, muscle mass, hunger, and metabolism once it binds to its receptor. Adlumiz has been proven to increase body weight, the muscular mass, and hunger in cancer patients with cachexia.

Market Coverage

· The market number available for - 2021-2028

· Base year- 2021

· Forecast period- 2020-2028

Segment Covered-

· By Product Type

· By Distribution Channel

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Ono Pharmaceutical Co., Ltd., and Pfizer Inc, among others.

(Get 15% Discount on Buying this Report)

A full Report of Global Incubator Devices Market is Available @ https://www.omrglobal.com/industry-reports/cancer-anorexia-cachexia-syndrome-drug-market

Global Anorexia Cachexia Syndrome Drug Market Report by Segment

By Treatment Type

· Progestogens

· Corticosteroids

· Combination therapies

By Distribution Channel

· Hospital Pharmacies

· Retail Pharmacies

· Online Pharmacies

Global Anorexia Cachexia Syndrome Drug Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights on the Cancer Anorexia Cachexia Syndrome Drug Market to 2022 | Industry Statistics, Emerging Demands, Forecast to 2028 here

News-ID: 2584438 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Adlumiz

Cancer Anorexia Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Cancer Anorexia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Anorexia Market Forecast https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Cancer Anorexia Market to Show Remarkable Growth Trends from 2024 to 2034, Delve …
The Key Cancer Anorexia Companies in the market include - Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others. DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Cancer Anorexia market outlook,
Cancer Anorexia Market to Reach New Heights in Growth by 2034, DelveInsight Pred …
DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Cancer Anorexia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cancer Anorexia Market Forecast https://www.delveinsight.com/sample-request/cancer-anorexia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Cancer Anorexia Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
The Key Cancer Anorexia Companies in the market include - Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others. DelveInsight's "Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cancer Anorexia, historical and forecasted epidemiology as well as the Cancer Anorexia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Cancer Anorexia market outlook,
Cancer Cachexia Market Size, Growth Analysis, Share, Key Trends And Forecast To …
The new report published by The Business Research Company, titled Cancer Cachexia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the cancer cachexia market size has grown strongly in recent years. It will grow from $2.33 billion in
Cancer Cachexia Market Analysis 2024-2033 : Forecast Market Size, Top Segments A …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Cancer Cachexia Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $3.14 billion In 2028 At